Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma
9 July 2020
PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis.
30 June 2020
A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models
26 June 2020
Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development
7 April 2020
The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review
1 February 2020
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
14 January 2020
SMARTer single cell total RNA sequencing
19 September 2019
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes
5 April 2019
Purification of high-quality RNA from a small number of fluorescence activated cell sorted zebrafish cells for RNA sequencing purposes
20 March 2019
DREAM target reactivation by core transcriptional regulators supports neuroblastoma growth
3 February 2019
Long noncoding RNA expression profiling in cancer: Challenges and opportunities
20 January 2019
ALK positively regulates MYCN activity through repression of HBP1 expression
11 December 2018
A mechanistic classification of clinical phenotypes in neuroblastoma
7 December 2018
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients
6 December 2018
In silico discovery of a FOXM1 driven embryonal signaling pathway in therapy resistant neuroblastoma tumors
30 November 2018
Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma
20 November 2018
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets
19 November 2018
A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing
28 June 2018
Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN
15 June 2018
Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia
18 April 2018
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients
5 March 2018
The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human disease
2 February 2018
Epigenetic regulation of neuroblastoma development
2 February 2018
Early and late effects of pharmacological ALK inhibition on the neuroblastoma transcriptome
5 December 2017
Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients
14 July 2017
T-ALL and thymocytes: a message of noncoding RNAs
7 March 2017
Stage 4S neuroblastoma tumors show a characteristic DNA methylation portrait
6 September 2016
Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia
10 May 2016
Neuroblastoma: A Tough Nut to Crack
1 January 2016
Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment
15 July 2015
MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkNoPrivacy policy
